
UAE study finds Sotrovimab prevents death among high-risk
A two-week evaluation on 6,175 Covid-19 patients in Abu Dhabi revealed that a 100% prevention of death among recipients and 99% prevention of admission to ICUs, reports Asian Lite News High-risk patients